Pneumothorax with prolonged chest tube requirement after CT-guided percutaneous lung biopsy: incidence and risk factors

European Radiology

Volumn 26, Issue 10, 2016, Pages 3483-3491

  Moreland, Anna ^a   Novogrodsky, Eitan ^a,b   Brody, Lynn ^a   Durack, Jeremy ^a   Erinjeri, Joseph ^a   Getrajdman, George ^a   Solomon, Stephen ^a   Yarmohammadi, Hooman ^a   Maybody, Majid ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biopsy; Chest tubes; Image guided biopsy; Lung; Pneumothorax

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY NEEDLE; CHEST TUBE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; HUMAN TISSUE; IMAGE GUIDED BIOPSY; INCIDENCE; INTERVENTIONAL RADIOLOGY; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT MONITORING; PATIENT POSITIONING; PERCUTANEOUS BIOPSY; PNEUMOTHORAX; PRIORITY JOURNAL; RESPIRATORY TRACT INTUBATION; RETROSPECTIVE STUDY; RISK FACTOR; ADVERSE EFFECTS; LUNG; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PROCEDURES; THORACOTOMY; TIME; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CHEST TUBES; FEMALE; HUMANS; IMAGE-GUIDED BIOPSY; INCIDENCE; LUNG; MALE; MIDDLE AGED; PNEUMOTHORAX; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; RISK FACTORS; THORACOTOMY; TIME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84954473578     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-015-4200-7     Document Type: Article

References (30)

1. Hirose T, Mori K, Machida S, Tominaga K, Yokoi K, Adachi M (2000) Computed tomographic fluoroscopy-guided transthoracic needle biopsy for diagnosis of pulmonary nodules. Jpn J Clin Oncol 30:259–262
2. Hur J, Lee HJ, Nam JE et al (2009) Diagnostic accuracy of CT fluoroscopy-guided needle aspiration biopsy of ground-glass opacity pulmonary lesions. AJR Am J Roentgenol 192:629–634
3. Tuna T, Ozkaya S, Dirican A, Findik S, Atici AG, Erkan L (2013) Diagnostic efficacy of computed tomography-guided transthoracic needle aspiration and biopsy in patients with pulmonary disease. Onco Targets Ther 6:1553–1557
4. Birchard KR (2011) Transthoracic needle biopsy. Semin Interv Radiol 28:87–97
5. Ayyappan AP, Souza CA, Seely J, Peterson R, Dennie C, Matzinger F (2008) Ultrathin fine-needle aspiration biopsy of the lung with transfissural approach: does it increase the risk of pneumothorax? AJR Am J Roentgenol 191:1725–1729
6. Sigel CS, Moreira AL, Travis WD et al (2011) Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens. J Thorac Oncol 6:1849–1856
7. Stewart CJ, Coldewey J, Stewart IS (2002) Comparison of fine needle aspiration cytology and needle core biopsy in the diagnosis of radiologically detected abdominal lesions. J Clin Pathol 55:93–97
8. Hiraki T, Mimura H, Gobara H et al (2010) Incidence of and risk factors for pneumothorax and chest tube placement after CT fluoroscopy-guided percutaneous lung biopsy: retrospective analysis of the procedures conducted over a 9-year period. AJR Am J Roentgenol 194:809–814
9. Covey AM, Gandhi R, Brody LA, Getrajdman G, Thaler HT, Brown KT (2004) Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients. J Vasc Interv Radiol 15:479–483
10. Gupta S, Hicks ME, Wallace MJ, Ahrar K, Madoff DC, Murthy R (2008) Outpatient management of postbiopsy pneumothorax with small-caliber chest tubes: factors affecting the need for prolonged drainage and additional interventions. Cardiovasc Intervent Radiol 31:342–348
11. Perlmutt LM, Braun SD, Newman GE et al (1987) Transthoracic needle aspiration: use of a small chest tube to treat pneumothorax. AJR Am J Roentgenol 148:849–851
12. Nakamura M, Yoshizako T, Koyama S, Kitagaki H (2011) Risk factors influencing chest tube placement among patients with pneumothorax because of CT-guided needle biopsy of the lung. J Med Imaging Radiat Oncol 55:474–478
13. Lim CS, Tan LE, Wang JY et al (2014) Risk factors of pneumothorax after CT-guided coaxial cutting needle lung biopsy through aerated versus nonaerated lung. J Vasc Interv Radiol 25:1209–1217
14. Rizzo S, Preda L, Raimondi S et al (2011) Risk factors for complications of CT-guided lung biopsies. Radiol Med 116:548–563
15. Saji H, Nakamura H, Tsuchida T et al (2002) The incidence and the risk of pneumothorax and chest tube placement after percutaneous CT-guided lung biopsy: the angle of the needle trajectory is a novel predictor. Chest 121:1521–1526
16. Geraghty PR, Kee ST, McFarlane G, Razavi MK, Sze DY, Dake MD (2003) CT-guided transthoracic needle aspiration biopsy of pulmonary nodules: needle size and pneumothorax rate. Radiology 229:475–481
17. Swischuk JL, Castaneda F, Patel JC et al (1998) Percutaneous transthoracic needle biopsy of the lung: review of 612 lesions. J Vasc Interv Radiol 9:347–352
18. Kazerooni EA, Lim FT, Mikhail A, Martinez FJ (1996) Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung. Radiology 198:371–375
19. Wu CC, Maher MM, Shepard JA (2011) Complications of CT-guided percutaneous needle biopsy of the chest: prevention and management. AJR Am J Roentgenol 196:W678–W682
20. Loiselle A, Parish JM, Wilkens JA, Jaroszewski DE (2013) Managing iatrogenic pneumothorax and chest tubes. J Hosp Med 8:402–408
21. Lokhandwala TDR, Johnson M, D'Souza AO (2014) Costs of the diagnostic workup for lung cancer— a medicare claims analysis. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2014.08.142
22. Brown KT, Brody LA, Getrajdman GI, Napp TE (1997) Outpatient treatment of iatrogenic pneumothorax after needle biopsy. Radiology 205:249–252
23. Moreira AL, Thornton RH (2012) Personalized medicine for non-small-cell lung cancer: implications of recent advances in tissue acquisition for molecular and histologic testing. Clin Lung Cancer 13:334–339
24. Johnson DH, Fehrenbacher L, Novotny WF et al (2004) Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 22:2184–2191
25. Scagliotti GV, Parikh P, von Pawel J et al (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26:3543–3551
26. Mok TS, Wu YL, Thongprasert S et al (2009) Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361:947–957
27. Wang ZJ, An TT, Mok T et al (2011) Immediate versus delayed treatment with egfr tyrosine kinase inhibitors after first-line therapy in advanced non-small-cell lung cancer. Chin J Cancer Res 23:112–117
28. Eberhard DA, Johnson BE, Amler LC et al (2005) Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol 23:5900–5909
29. Kwak EL, Bang YJ, Camidge DR et al (2010) Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363:1693–1703
30. Vatrella A, Galderisi A, Nicoletta C et al (2014) Age as a risk factor in the occurrence of pneumothorax after transthoracic fine needle biopsy: our experience. Int J Surg 12:S29–S32